Arkolith/Insider Trading/ENZ/Form 4

Erfanian Hamid

Chief Executive Officer, DirectorENZO BIOCHEM INC (ENZ) · full profile →Form 4 · filed Nov 28, 2022
Net Buying
Open-Market Buys
$197K
Open-Market Sells
$0
Net Open-Market Flow
$197K
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 23, 2022Buy(P)100K$1.97$197K375K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 23, 2022Grant(A)300K—$0300K

Transaction Codes

P
Open-market purchase
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-22-075598) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML